Antibe Therapeutics Inc. ATE.TO
0.30 +0.30
Day range unavailable
52-week range unavailable
Ownership
Held by insiders 7.94%
Held by institutions 0.00%
Float held by institutions 0.00%
Institutions 0
Top institutional holders
No holders on record
Top mutual fund holders
No holders on record
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| Curtis (Scott Wilson) | Senior Officer of Issuer | Acquisition or disposition in the public market | Nov 14, 2022 | 100,000 |
| Flower, Roderick John | Director of Issuer | Exercise of rights | Nov 14, 2022 | 151,468 |
| Hoffman (Robert) | Director of Issuer | Exercise of rights | Nov 14, 2022 | 13,334 |
| Khouri, Amal | Director of Issuer | Exercise of rights | Nov 14, 2022 | 1,667 |
| Legault (Daniel Marcel) | Director of Issuer | Acquisition or disposition in the public market | Nov 14, 2022 | 983,296 |
| Mcnealey Jennifer Isacoff | Director of Issuer | Exercise of rights | Nov 14, 2022 | 13,334 |